Clinical Trials Browser

Uveal Melanoma, Astrocytoma, Carcinoma, Renal Cell, Medulloblastoma, Melanoma, Neoplasms, Wilms Tumor, Neuroblastoma, Neutropenia, Retinoblastoma, Osteosarcoma, Testicular Neoplasms, Thrombocytopenia, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Gestational Trophoblastic Disease

NCT00008424 2014-05-05

Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants

Phase 1 Completed

7 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00006095 2014-02-21

Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

Phase 1 Completed

20 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00006463 2014-02-21

Ecteinascidin 743 in Treating Children With Refractory Solid Tumors

Phase 1 Completed

13 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00070473 2014-02-20

Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors

Phase 1 Completed

33 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT01048892 2014-01-30

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Phase 1 Completed

22 enrolled

CNSEndocrineGenitourinaryOther solid neoplasmSarcoma

Kidney Neoplasms, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Adrenocortical Carcinoma

NCT00387504 2013-09-12

Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Phase 1 Completed

21 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004886 2012-09-24

MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006354 2012-07-24

Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Phase 1 Completed

41 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00027677 2012-07-24

Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors

Phase 1 Completed

25 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005061 2012-07-18

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

20 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006477 2012-07-18

Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors

Phase 1 Completed

26 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003976 2012-07-11

E7070 in Treating Patients With Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003979 2012-07-11

CHS 828 in Treating Patients With Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003980 2012-07-11

BIBX 1382 in Treating Patients With Solid Tumors

Phase 1 Suspended

80 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003981 2012-07-11

E7070 in Treating Patients With Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00002904 2012-07-02

Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors

Phase 1 Completed

40 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003028 2012-07-02

MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors

Phase 1 Completed

5 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006246 2009-10-07

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Phase 1 Completed

28 enrolled

CNSLymphoidOther hematologic neoplasmOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Leukemia, Lymphoma, Medulloblastoma, Neoplasm Metastasis, Oligodendroglioma, Recurrence, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Meningeal Carcinomatosis

Clinical Trials

AEG35156 and Docetaxel in Treating Patients With Solid Tumors

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors

MG98 in Treating Patients With Advanced Solid Tumors

VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors

S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants

Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

Ecteinascidin 743 in Treating Children With Refractory Solid Tumors

Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors

Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors

E7070 in Treating Patients With Solid Tumors

CHS 828 in Treating Patients With Solid Tumors

BIBX 1382 in Treating Patients With Solid Tumors

E7070 in Treating Patients With Solid Tumors

Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors

MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer